The influence of the human body on the fate of Celebrex for the prevention/treatment of colorectal cancer: plasma concentration and elimination of Celebrex in healthy volunteers

Primary objectives: To study the pharmacokinetics of Celecoxib for the prevention/treatment of colorectal cancer Primary endpoints: The pharmacokinetic profiling of Celecoxib following oral administration in healthy volunteers